- Home
- SND vs QNCX Comparison
SND vs QNCX Comparison
Compare SND & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- QNCX
- Stock Information
- Founded
- SND 2011
- QNCX 2012
- Country
- SND United States
- QNCX United States
- Employees
- SND N/A
- QNCX N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SND Industrials
- QNCX Health Care
- Exchange
- SND Nasdaq
- QNCX Nasdaq
- Market Cap
- SND 85.6M
- QNCX 88.6M
- IPO Year
- SND 2016
- QNCX 2019
- Fundamental
- Price
- SND $2.52
- QNCX $1.70
- Analyst Decision
- SND
- QNCX Strong Buy
- Analyst Count
- SND 0
- QNCX 4
- Target Price
- SND N/A
- QNCX $7.75
- AVG Volume (30 Days)
- SND 130.6K
- QNCX 343.3K
- Earning Date
- SND 11-12-2025
- QNCX 11-12-2025
- Dividend Yield
- SND 4.00%
- QNCX N/A
- EPS Growth
- SND N/A
- QNCX N/A
- EPS
- SND 0.10
- QNCX N/A
- Revenue
- SND $335,471,000.00
- QNCX N/A
- Revenue This Year
- SND N/A
- QNCX N/A
- Revenue Next Year
- SND N/A
- QNCX N/A
- P/E Ratio
- SND $24.73
- QNCX N/A
- Revenue Growth
- SND 18.98
- QNCX N/A
- 52 Week Low
- SND $1.76
- QNCX $0.72
- 52 Week High
- SND $2.77
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- SND 72.84
- QNCX 49.01
- Support Level
- SND $2.09
- QNCX $1.44
- Resistance Level
- SND $2.19
- QNCX $1.84
- Average True Range (ATR)
- SND 0.09
- QNCX 0.12
- MACD
- SND 0.03
- QNCX 0.00
- Stochastic Oscillator
- SND 87.23
- QNCX 62.50
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.